Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) — Stella

Recruiting

Back to Microvascular Angina trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Qilu Hospital of Shandong University, Jinan, Shandong

Key details

Phase

Post-approval study

Sponsor

Qilu Hospital of Shandong University

Enrollment target

~100 participants

Started

December 2018

Primary completion

June 2027

Age range

30 Years – 75 Years

Last updated October 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov